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Abstract
Dipyrone (Dp), 4-aminoantipyrine (AA), and antipyrine (At) delay liquid gastric emptying (GE) in rats. We evaluated adrenergic
participation in this phenomenon in a study in male Wistar rats (250-300 g) pretreated subcutaneously with guanethidine
(GUA), 100 mg?kg–1?day–1, or vehicle (V) for 2 days before experimental treatments. Other groups of animals were pretreated
intravenously (iv) 15 min before treatment with V, prazosin (PRA; 1 mg/kg), yohimbine (YOH; 3 mg/kg), or propranolol (PRO;
4 mg/kg), or with intracerebroventricular (icv) administration of 25 mg PRO or V. The groups were treated iv with saline or with
240 mmol/kg Dp, AA, or At. GE was determined 10 min later by measuring the percentage of gastric retention (%GR) of saline
labeled with phenol red 10 min after gavage. %GR (mean±SE, n=8) indicated that GUA abolished the effect of Dp (GUA vs
V=31.7±1.6 vs 47.1±2.3%) and of At (33.2±2.3 vs 54.7±3.6%) on GE and significantly reduced the effect of AA (48.1±3.2
vs 67.2±3.1%). PRA and YOH did not modify the effect of the drugs. %GR (mean±SE, n=8) indicated that iv, but not icv,
PRO abolished the effect of Dp (PRO vs V=29.1±1.7 vs 46.9±2.7%) and At (30.5±1.7 vs 49±3.2%) and significantly
reduced the effect of AA (48.4±2.6 vs 59.5±3.1%). These data suggest activation of peripheral b-adrenoceptors in the
delayed GE induced by phenylpyrazolone derivatives.
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Introduction
The mechanisms involved in delayed gastric emptying
(GE) of liquid in rats induced by the phenylprazolone
derivatives dipyrone (Dp), 4-aminoantipyrine (AA), and
antipyrine (At) are unknown, although there is evidence
that 1) these drugs increase gastric compliance and 2) the
vagus nerve, the central nervous system (CNS), and
afferent capsaicin-sensitive pathways participate in the
phenomenon (1-5).
The sympathetic nervous system (SNS), which has a
limited effect on the gastrointestinal tract under physiolo-
gical conditions, releases norepinephrine in postganglionic
endings. Under certain conditions involving imbalanced
homeostasis, acting as a defense mechanism, it interferes
with the normal control of intestinal function, reducing
motility and inhibiting secretion (6).
In the rat, the prevertebral sympathetic ganglia differ in
organization from those of other species. The celiac
ganglion and superior mesenteric ganglion project fibers
toward the stomach, small intestine, and proximal colon.
The stomach mostly receives fibers originating in the celiac
ganglion (7).
Activation of the presynaptic a2-adrenoceptors located
in the vagus nerve results in reduced acetylcholine
release from cholinergic nerve endings. Activation of
the a2B-adrenoceptor subtype protects the gastric
mucosa, and activation of the a2A-adrenoceptor
subtype may be responsible for the inhibition of GE in
rats (8). On the other hand, b1- and b2-adrenoceptors
have been detected mainly in smooth muscle cells of
the digestive tract of rats (9). An in vitro study revealed
that, among the b-adrenergic subtypes, b3-adrenoceptors
are those that predominantly participate in the relaxa-
tion of the gastric fundus of rats induced by catechola-
mines (10).
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Under certain experimental conditions involving delayed
GE in rats, there is evidence that the condition can be
partially or fully reversed by blockade of one of these
adrenoceptors (8,11-14). On this basis, considering that the
SNS may interfere with the control of GE, it is reasonable to
speculate about a possible SNS involvement in the
phenomenon induced by phenylpyrazolone derivatives. In
the present study, we evaluated adrenergic participation in
the GE delay induced by Dp, AA, and At in rats by 1) acute
adrenergic blockade induced by guanethidine and 2)
adrenoceptor blockade by a-adrenergic antagonists, and
a nonselective b-adrenergic antagonist.
Material and Methods
The study was conducted on male Wistar rats
weighing 250-300 g, and adapted to laboratory conditions
for at least 2 weeks. The study was approved by the
Ethics Committee for Animal Experimentation of
Universidade Estadual de Campinas (UNICAMP; protocol
No. 1372-1).
The animals were maintained in individual cages with
free access to food until 24 h and water until 30 min
before the evaluation of GE from 1:00 to 4:00 pm. A
similarly maintained group of animals was sedated with
75 mg/kg thiopental administered intraperitoneally (ip) 8
days before admission to the study and were implanted
with a cannula in the right lateral ventricle, positioned as
previously described (1).
Solutions of Dp, AA, At, guanethidine sulfate (GUA),
prazosin (PRA), yohimbine (YOH), and propranolol (PRO),
all from Sigma (USA), in sterile saline as the vehicle (V),
were prepared at the time of use, and, when indicated,
were protected from light. Sterile saline, adjusted to pH 7.4,
was used to prepare the GUA solution (15). The doses of
each drug used were based on the literature and were
tested in the laboratory in preliminary studies.
In the study of guanethidine-induced adrenergic
blockade, the GUA group was pretreated with 100 mg/kg
GUA administered subcutaneously (sc) at 4:00 pm for 2
consecutive days, as indicated in the literature (15). Control
animals (V group) received 1 mL/kg saline vehicle by the
same route.
In subsequent studies, a 15-min interval was allowed
between pretreatment and treatment. Intravenous (iv)
pretreatment with the a-adrenergic antagonists was given
to three groups as follows. The PRA group was pretreated
with 1 mg/kg PRA (an a1- and a2B-adrenergic antagonist).
The YOH group was pretreated with 3 mg/kg YOH
(a nonselective a2-adrenergic antagonist), and a control
group was pretreated with 1 mL/kg saline (V group). The
PRA and YOH doses used were those recommended in the
literature (11), which correspond approximately to 8 and 1.5
times higher values, respectively, than those employed iv
in a study of the effect of a-adrenergic agonists on gastric
motility in rats (16).
The animals pretreated with the nonselective
b-adrenergic antagonist propranolol (PRO group) were
pretreated ivwith 4 mg/kg of the drug, a dose determined in
a preliminary study from our laboratory, and the control
group was pretreated with 1 mL/kg saline vehicle (V group).
For intracerebroventricular (icv) pretreatment with
propranolol, 25 mg/animal (PRO group) or 10 mL saline
(V group) was used. The technique used and the volume
administered were established in previous studies from
our laboratory (1,3,4), and the dose of propranolol was
determined in a preliminary study that showed that higher
doses result per se in a discrete and progressive delay of
GE that might compromise the study.
As done in previous studies (1-5), all groups were
treated iv with 240 mmol/kg Dp, AA, or At or with 1 mL/kg
sterile saline solution (S) vehicle control, and GE was
determined 10 min after treatment.
GE was assessed indirectly in awake animals by
determining the percentage of gastric retention (%GR) of
a saline test meal labeled with 60 mg/mL phenol red
10 min after administration by gavage in a volume of
2 mL/100 g rat weight according to a technique standar-
dized in our laboratory (17), with some modifications (5).
In the animals implanted with a cannula in the lateral
ventricle, the location of the cannula was determined by
icv injection of 10 mL 1% Evans blue solution at the end of
the GE study. After the rats in this group were killed, their
brains were removed and fixed in 10% formalin. Coronal
sections were obtained and icv injection was confirmed by
detection of the dye in the IV ventricle, as done in previous
studies (1-4).
Data were analyzed statistically by ANOVA and pair
comparisons were performed using the Tukey test, with
the level of significance set at a=0.05 for both tests.
Results
Figure 1 illustrates the results of sc pretreatment with
GUA (%GR, mean±SE, n=8), which did not modify GE
in the animals treated with vehicle (29.5±1.3%) com-
pared to their controls (24.9±1.8%). On the other hand,
pretreatment with GUA abolished the effect of Dp
(31.7±1.6%) and At (33.2±2.3%) compared with the
controls pretreated with vehicle (47.1±2.3 and
54.7±3.6%, respectively) and significantly reduced the
effect of AA (48.1±3.2%) compared with controls
(67.3±3.1%).
The results of %GR (Table 1) for rats pretreated iv with
PRA or YOH and treated with Dp, AA, or At did not differ
significantly from those of rats pretreated with vehicle and
treated with the same drugs. The animals pretreated with
PRA or YOHand treated with saline did not differ significantly
from those pretreated with V and then treated with S.
Figure 2 illustrates the results of iv pretreatment
with PRO. The %GR values (mean±SE, n=8) showed
that this pretreatment did not modify GE in animals
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subsequently treated iv with S (24.6±1.2%) compared
with their controls (25.5±1.6%). In contrast PRO pre-
treatment abolished the effects of Dp (29.1±1.7%) and At
(30.5±1.7%) compared with their controls pretreated with
V (46.9±2.7 and 49±3.2%, respectively), and signifi-
cantly reduced the effect of AA (48.4±2.6%) compared
with controls (59.5±3.1%).
The mean±SE %GR in rats (n=8) pretreated with
25 mg/animal PRO icv and then treated iv with Dp
(53.2±2.8%), AA (54.2±3.9%), or At (44.4±2.5%) did
not differ significantly from that observed in rats pretreated
icv with vehicle (10 mL/animal) and treated with the same
drugs (50.1±2.0, 58.2±2.8, and 44.9±3.4%, respec-
tively). The %GR in animals pretreated with PRO and
treated with S (31.2±2.1%) did not differ from that in
animals pretreated with V and treated with S (25.3±1.4%).
Discussion
Treatment with guanethidine sulfate for a few days
blocks the release of norepinephrine from peripheral
sympathetic nerves in adult rats (15). In the present study,
sc pretreatment with this drug (100 mg/kg) for 2 days (15)
abolished the delayed GE of a liquid meal induced by
dipyrone and antipyrine and significantly reduced, but did
not abolish, the effect of 4-aminoantipyrine (Figure 1),
suggesting the involvement of the SNS in this phenomenon.
Pretreatment with prazosin, an a1- and a2B-adrenergic
antagonist, or yohimbine, a nonselective a2-adrenergic
antagonist (8,16), did not interfere with the effect of the
three phenylpyrazolone derivatives on GE (Table 1),
indicating that the participation of these receptors in the
delay is unlikely.
Similar to the results obtained with guanethidine,
pretreatment with propranolol, a classical nonselective
b-adrenergic antagonist (18), abolished the effect of
dipyrone and antipyrine on GE and significantly reduced,
but did not abolish, the effect of 4-aminoantipyrine (Figure
2), indicating that the peripheral adrenergic receptors
involved may be b-adrenergic.
However, considering that propranolol is highly lipo-
philic and rapidly crosses the blood-brain barrier (19), the
results may also be due, at least in part, to its action on
Table 1. Fractional gastric retention (%GR) of a liquid meal (saline) 10 min after administration to rats by gavage.
Pretreatment (iv) Treatment (iv)
S Dp AA At
V 28.4 ± 1.1 51.0 ± 2.2a 62.5 ± 3.1a 49.7 ± 3.4a
PRA 21.9 ± 1.0 49.0 ± 3.8b 64.1 ± 2.8b 50.0 ± 5.1b
YOH 34.6 ± 1.3 49.6 ± 3.6c 52.1 ± 4.6c 51.2 ± 3.8c
Data are reported as mean±SE%GR for 8 rats. The animals were pretreated with saline as a vehicle (V), 1 mg/kg prazosin (PRA) or 3
mg/kg yohimbine (YOH) and treated with saline (S), 240 mmol/kg dipyrone (Dp), 240 mmol/kg 4-aminoantipyrine (AA) or 240 mmol/kg
antipyrine (At). P,0.05 vs aV+S, bPRA+S, and cYOH+S, respectively (Tukey test).
Figure 1. Gastric retention (%) of a saline test meal 10 min after
administration to rats by gavage. The animals were pretreated
(Pretreat) sc with saline as a vehicle (V) or with guanethidine
sulfate (GUA, 100 mg?kg-1?day-1) for 2 days before the iv
treatments (Treat) with saline (S) or 240 mmol/kg dipyrone (Dp),
4-aminoantipyrine (AA) or antipyrine (At). The test meal was
administered 10 min after the treatment. Data are reported as
means±SE for 8 animals per group. *P,0.05 (Tukey test).
Figure 2. Gastric retention (%) of a saline test meal 10 min after
administration to rats by gavage. The animals were pretreated
(Pretreat) iv with saline as a vehicle (V) or with 4 mg/kg
propranolol (PRO), 15 min before the iv treatments (Treat) with
saline (S) or 240 mmol/kg dipyrone (Dp), 4-aminoantipyrine (AA)
or antipyrine (At). The test meal was administered 10 min after
the treatment. Data are reported as means±SE for 8 animals per
group. *P,0.05 (Tukey test).
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the CNS. In rats, b1- and b2-adrenoceptors have been
identified in various regions of the CNS (20). However,
since icv administration of the nonselective b-antagonist
did not modify the effect of the three study drugs, this
hypothesis is unlikely. On the other hand, this observation
supports the possibility of participation of peripheral b-
adrenoceptors in this phenomenon.
On the basis of the experimental conditions of the
present study, it is clear that the adrenergic blockade
induced by guanethidine and propranolol did not abolish the
effect of 4-aminoantipyrine. Thus, it is possible that another
mechanism in addition to the activation of b-adrenergic
receptors may participate in the effect of this drug on GE.
Previous reports have shown the involvement of
b-adrenoceptors in other situations where GE has been
altered experimentally. In rat models of motion sickness (12)
and restraint stress (13) in which GE is reduced, propranolol
blocked the effect of the procedure. Another observation
demonstrated that b3-adrenceptors play an important role in
the inhibition of GE caused by restraint stress in rats,
whereas nonspecific adrenoceptors are involved in the GE
inhibition induced by treatment with norepinephrine (14).
Since propranolol has high affinity for the b1- and b2-
adrenoceptor subtypes and low affinity for the b3-adrenergic
subtype (18), at this stage of our study we cannot yet
conclude which subtype or subtypes are involved.
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